Novonesis (Novozymes) B
NSISBC
Rangering i aksjer
#1144
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Aksjekurs
$71.20
Markedsverdi
$19.79B
Endring (1 dag)
1.56%
Endring (1 år)
12.29%
Land
DK
Handel Novonesis (Novozymes) B (NSISBC)
Kategori
Basic Materials
Aksjeprishistorikk for Novonesis (Novozymes) B (NSISBC)
Høyeste sluttskurs: $69.83 den 2026-10-01
Laveste sluttskurs: $58.74 den 2024-03-01
Laveste sluttskurs: $58.74 den 2024-03-01
Aksjeprishistorikk for Novonesis (Novozymes) B fra 2024 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 1.89% |
| 2025 | 7.42% |
| 2024 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $504.45 | 12.12% |
GB
|
|
| $194.75 | 7.01% |
FR
|
|
| $343.16 | 2.80% |
US
|
|
| $291.85 | 5.74% |
US
|
|
| $304.24 | 20.18% |
US
|
